Skip to content
GK24
Science & TechnologyEasy

How many clinical trial sites will be adopted under the NIPER Raebareli and AstraZeneca India collaboration?

  1. A.10
  2. B.25
  3. C.50
  4. D.100

Correct answer

B. 25

Explanation

The correct answer is 25. The partnership begins by adopting 25 clinical trial sites in emerging research geographies, assessing what each can do, and then giving the staff targeted training and mentoring while tightening documentation and the processes around ethics, safety and trial feasibility. Options A, C and D are not the figure in the agreement and are offered because round numbers look convincing in a question of this kind. Candidates should be careful to separate this number from the larger mission target: the government's Biopharma SHAKTI initiative speaks of setting up a thousand clinical trial sites across the country, so the sites taken up here form an early instalment of that goal, not the goal itself. The purpose of picking emerging geographies is to carry trial capability beyond the metros, widening both the pool of trained professionals and the number of inspection-ready research sites.

Read the full article: NIPER Raebareli, AstraZeneca Tie Up for 25 Trial Sites

Q1.Science & TechnologyMedium

The clinical research collaboration signed at New Delhi advances which flagship government initiative?

  1. A.Biopharma SHAKTI
  2. B.Ayushman Bharat
  3. C.Mission Indradhanush
  4. D.PRIP Scheme
Show answer
Correct answer: A. Biopharma SHAKTI

It is described as the central government's flagship initiative for building a stronger biopharma ecosystem, and among its goals is the creation of a thousand clinical trial sites across the country; the partnership between NIPER Raebareli and AstraZeneca India directly serves that objective.

Read the full explanation →
Q2.Science & TechnologyMedium

Who is the Director of NIPER Raebareli, quoted on the proposed Centre of Excellence?

  1. A.Manoj Joshi
  2. B.Dr Shubhini Saraf
  3. C.Praveen Rao Akkinepally
  4. D.Dr M L Jat
Show answer
Correct answer: B. Dr Shubhini Saraf

As Director of NIPER Raebareli she said the proposed Centre of Excellence would serve as a dedicated platform for structured training and certification in clinical research, and that bringing academic and industry expertise together would produce a model capable of being repeated in other regions and therapeutic areas.

Read the full explanation →
Q3.Science & TechnologyEasy

Which body signed the YETI development agreement with ideaForge Technology Limited?

  1. A.Defence Research and Development Organisation
  2. B.Technology Development Board
  3. C.Indian Space Research Organisation
  4. D.Council of Scientific and Industrial Research
Show answer
Correct answer: B. Technology Development Board

The TDB works under the Department of Science and Technology and it is the body that signed the agreement with ideaForge Technology Limited of Mumbai for support under the Research Development and Innovation Fund.

Read the full explanation →